Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies

References

• Aksu, B., et al., 2010. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats. Acta Histochemica, 112(3), 259–269.
   PubMed Web of Science ®Google Scholar
• Apel, K., and Hirt, H., 2004. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annual Review of Plant Biology, 55, 373–399.
   PubMed Web of Science ®Google Scholar
• Arauz, J., Ramos-Tovar, E., and Muriel, P., 2016. Redox state and methods to evaluate oxidative stress in liver damage: From bench to bedside. Annals of Hepatology, 15(2), 160–173.
   PubMed Web of Science ®Google Scholar
• Baskol, M., Dolbun Seckin, K., and Baskol, G., 2015. Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash. The Turkish Journal of Gastroenterology, 25(1), 32–37.
   Google Scholar
• Bayr, H., 2005. Reactive oxygen species. Critical Care Medicine, 33(Suppl), S498–S501.
   PubMedGoogle Scholar
• Bellentani, S., 2017. The epidemiology of non‐alcoholic fatty liver disease. Liver International, 37, 81–84.
   PubMed Web of Science ®Google Scholar
• Benzie, I.F., and Strain, J., 1996. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay . Analytical Biochemistry, 239(1), 70–76.
   PubMed Web of Science ®Google Scholar
• Borrelli, A., et al., 2018. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches. Redox Biology, 15, 467–479.
   PubMed Web of Science ®Google Scholar
• Cheng, D.L., et al., 2018. Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model. Experimental and Therapeutic Medicine, 16(6), 5227–5235.
   PubMed Web of Science ®Google Scholar
• Cichoż-Lach, H., and Michalak, A., 2014. Oxidative stress as a crucial factor in liver diseases. World Journal of Gastroenterology, 20(25), 8082.
   PubMed Web of Science ®Google Scholar
• Das, S., et al., 2008. Evaluation of blood oxidative stress‐related parameters in alcoholic liver disease and non‐alcoholic fatty liver disease. Scandinavian Journal of Clinical and Laboratory Investigation, 68(4), 323–334.
   PubMed Web of Science ®Google Scholar
• Del Ben, M., et al., 2014. NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterology, 14(1), 81.
   PubMedGoogle Scholar
• Doustimotlagh, A.H., et al., 2014. Alteration in membrane protein, antioxidant status and hexokinase activity in erythrocytes of CCl^ sub 4^-induced cirrhotic rats. Acta Medica Iranica, 52(11), 795.
   PubMedGoogle Scholar
• Dowman, J.K., Tomlinson, J., and Newsome, P., 2010. Pathogenesis of non-alcoholic fatty liver disease. QJM: Monthly Journal of the Association of Physicians, 103(2), 71–83.
   PubMed Web of Science ®Google Scholar
• Elsheikh, E., et al., 2017. Inducible nitric oxide synthase is independently associated with the increased hepatic steatosis in patients with Nonalcoholic Fatty Liver Disease (NAFLD). Gastroenterology, 152(5), S684–S5.
   Web of Science ®Google Scholar
• Farhan, A.R., 2018. Evaluation of melatonin hormone and nitric oxide levels in non-alcoholic fatty liver patients in relation to obesity and oxidative stress. Journal of Pharmaceutical Sciences and Research, 10(5), 1167–1169.
   Google Scholar
• Fassihi, A., et al., 2012. Synthesis, calcium-channel blocking activity, and conformational analysis of some novel 1, 4-dihydropyridines: application of PM3 and DFT computational methods. Medicinal Chemistry Research, 21(10), 2749–2761.
   Web of Science ®Google Scholar
• Fisher, C.L., et al., 1994. The role of arginine 143 in the electrostatics and mechanism of Cu, Zn superoxide dismutase: computational and experimental evaluation by mutational analysis. Proteins: Structure, Function, and Genetics, 19(1), 24–34.
   PubMed Web of Science ®Google Scholar
• García-Monzón, C., et al., 2000. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. Journal of Hepatology, 32(2), 331–338.
   PubMed Web of Science ®Google Scholar
• Gupta, R.K., et al., 2012. Interactions between oxidative stress, lipid profile and antioxidants in breast cancer: a case control study. Asian Pacific Journal of Cancer Prevention, 13(12), 6295–6298.
   PubMedGoogle Scholar
• Hamaguchi, M., et al., 2007. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. The American Journal of Gastroenterology, 102(12), 2708.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., and Schulten, K., 1996. VMD: visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38.
   PubMedGoogle Scholar
• Ihsan, A.U., et al., 2018. Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress. Biomedicine &Amp; Pharmacotherapy = Biomedecine & Pharmacotherapie, 106, 714–723.
   PubMed Web of Science ®Google Scholar
• Javadian, N., et al., 2016. The modulatory effect of nitric oxide in pro-and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice. Epilepsy Research, 126, 134–140.
   PubMed Web of Science ®Google Scholar
• Koruk, M., et al., 2004. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Annals of Clinical & Laboratory Science, 34(1), 57–62.
   PubMed Web of Science ®Google Scholar
• Lei, X.G., et al., 2016. Paradoxical roles of antioxidant enzymes: basic mechanisms and health implications. Physiological Reviews, 96(1), 307–364.
   PubMed Web of Science ®Google Scholar
• Li, S., et al., 2015. The role of oxidative stress and antioxidants in liver diseases. International Journal of Molecular Sciences, 16(11), 26087–26124.
   PubMed Web of Science ®Google Scholar
• Madan, K., et al., 2006. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. World Journal of Gastroenterology, 12(21), 3400–3405.
   PubMed Web of Science ®Google Scholar
• Mahdavi, M., et al., 2016. Evaluation of the cytotoxic, apoptosis inducing activity and molecular docking of spiroquinazolinone benzamide derivatives in MCF-7 breast cancer cells. Chemico-Biological Interactions, 260, 232–242.
   PubMed Web of Science ®Google Scholar
• Mansourian, M., et al., 2013. Linear and nonlinear QSAR modeling of 1, 3, 8-substituted-9-deazaxanthines as potential selective A 2B AR antagonists. Medicinal Chemistry Research, 22(10), 4549–4567.
   Web of Science ®Google Scholar
• Mansourian, M., et al., 2015. Insights into the human A1 adenosine receptor from molecular dynamics simulation: structural study in the presence of lipid membrane. Medicinal Chemistry Research, 24(10), 3645–3659.
   Web of Science ®Google Scholar
• Mansourian, M., Sadeghi, H., and Doustimotlagh, A., 2018. Activation of the glutathione peroxidase by metformin in the bile-duct ligation-induced liver injury: in vivo combined with molecular docking studies. Current Pharmaceutical Design, 24(27), 3256–3263.
   PubMed Web of Science ®Google Scholar
• Melissas, J., et al., 2006. Plasma antioxidant capacity in morbidly obese patients before and after weight loss. Obesity Surgery, 16(3), 314–320.
   PubMed Web of Science ®Google Scholar
• Mladenov, M., et al., 2015. The relationship between antioxidant enzymes and lipid peroxidation in senescent rat erythrocytes. Physiological Research, 64(6), 891–896.
   PubMed Web of Science ®Google Scholar
• Morris, G.M., et al., 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662.
   Web of Science ®Google Scholar
• Morris, G.M., et al., 2009. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791.
   PubMed Web of Science ®Google Scholar
• Narasimhan, S., et al., 2010. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clinical Biochemistry, 43(10-11), 815–821.
   PubMed Web of Science ®Google Scholar
• Nasab, R.R., Mansourian, M., and Hassanzadeh, F., 2018. Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives. Research in Pharmaceutical Sciences, 13(3), 213–221.
   PubMed Web of Science ®Google Scholar
• Nelson, J.E., et al., 2011. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.), 53(2), 448–457.
   PubMed Web of Science ®Google Scholar
• Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95(2), 351–358.
   PubMed Web of Science ®Google Scholar
• Peng, C.-H., et al., 2018. Mulberry Leaf Extracts prevent obesity-induced NAFLD with regulating adipocytokines, inflammation and oxidative stress. Journal of Food and Drug Analysis, 26(2), 778–787.
   PubMed Web of Science ®Google Scholar
• Perry, J., et al., 2010. The structural biochemistry of the superoxide dismutases. Biochimica et Biophysica Acta (Bba) - Proteins and Proteomics, 1804(2), 245–262.
   PubMed Web of Science ®Google Scholar
• Pirgon, Ö., et al., 2013. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. Journal of Clinical Research in Pediatric Endocrinology, 5(1), 33.
   PubMed Web of Science ®Google Scholar
• Rakhit, R., et al., 2002. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. The Journal of Biological Chemistry, 277(49), 47551–47556.
   PubMed Web of Science ®Google Scholar
• Reid, A.E., 2001. Nonalcoholic steatohepatitis. Gastroenterology, 121(3), 710–723.
   PubMed Web of Science ®Google Scholar
• Rinella, M.E., 2015. Nonalcoholic fatty liver disease: a systematic review. JAMA, 313(22), 2263–2273.
   PubMed Web of Science ®Google Scholar
• Rolo, A.P., Teodoro, J.S., and Palmeira, C.M., 2012. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biology & Medicine, 52(1), 59–69.
   PubMed Web of Science ®Google Scholar
• Rukmini, M., D’souza, B., and D’souza, V., 2004. Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients. Indian Journal of Clinical Biochemistry, 19(2), 114–118.
   PubMedGoogle Scholar
• Sakaguchi, S., et al., 2011. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. Drug Metabolism and Pharmacokinetics, 26(1), 30–46.
   PubMed Web of Science ®Google Scholar
• Shin, D.S., et al., 2009. Superoxide dismutase from the eukaryotic thermophile Alvinella pompejana: structures, stability, mechanism, and insights into amyotrophic lateral sclerosis. Journal of Molecular Biology, 385(5), 1534–1555.
   PubMed Web of Science ®Google Scholar
• Strange, R.W., et al., 2006. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. Journal of Molecular Biology, 356(5), 1152–1162.
   PubMed Web of Science ®Google Scholar
• Takaki, A., Kawai, D., and Yamamoto, K., 2013. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). International Journal of Molecular Sciences, 14(10), 20704–20728.
   PubMed Web of Science ®Google Scholar
• van de Wier, B., et al., 2013. Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production. FEBS Letters, 587(15), 2461–2466.
   PubMed Web of Science ®Google Scholar
• VIDELA, L.A., et al., 2004. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clinical Science (London, England : 1979), 106(3), 261–268.
   PubMed Web of Science ®Google Scholar
• Wallace, A.C., Laskowski, R.A., and Thornton, J.M., 1995. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, Design and Selection, 8(2), 127–134.
   Web of Science ®Google Scholar
• Weston, S.R., et al., 2005. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology (Baltimore, Md.), 41(2), 372–379.
   PubMed Web of Science ®Google Scholar
• Yoneda, M., et al., 2009. Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non‐alcoholic fatty liver disease. Hepatology Research, 39(10), 963–971.
   PubMed Web of Science ®Google Scholar
• Zhou, Y., et al., 2018. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. Biomedicine & Pharmacotherapy, 97, 1397–1408.
   PubMed Web of Science ®Google Scholar